Amivantamab plus lazertinib in post-osimertinib, post-platinum chemotherapy EGFR-mutant non-small cell lung cancer (NSCLC): Preliminary results from CHRYSALIS-2
No Thumbnail Available
Identifiers
Date
2021-09-21
Authors
Shu, C. A.
Goto, K.
Ohe, Y.
Besse, B.
Park, K.
Wang, Y.
Griesinger, F.
Yang, J. C-H.
Felip, E.
Sanborn, R. E.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
